Literature DB >> 28681210

Sebaceous Carcinoma: A Review of the Scientific Literature.

Thomas Knackstedt1, Faramarz H Samie2.   

Abstract

OPINION STATEMENT: Sebaceous carcinoma is a rare and potentially aggressive cutaneous malignancy. Commonly reported in the periocular area and the head and neck region, sebaceous carcinoma can arise from any sebaceous gland in the skin. The clinical presentation may be nonspecific, and a biopsy is important to establish a diagnosis and to differentiate from mimickers including benign sebaceous neoplasms, other adnexal tumors, and basal cell carcinoma. A diagnosis of Muir Torre syndrome should be considered in patients presenting with a sebaceous neoplasm. Early treatment is important given the potential of sebaceous carcinoma to spread to the regional lymph nodes and beyond. Sentinel lymph node biopsy and imaging to complete tumor staging may be indicated for larger or more aggressive tumors. Surgery, including Mohs micrographic surgery, remains the primary treatment modality for sebaceous carcinoma. Mohs micrographic surgery has the advantage of complete margin evaluation and low recurrence rates. Advanced cases may be treated with orbital exenteration, radiation therapy, chemotherapy, or combination therapy.

Entities:  

Keywords:  Extraocular sebaceous carcinoma; Eyelid tumors; Nonmelanoma skin cancer; Periocular cancers; Sebaceous carcinoma

Mesh:

Year:  2017        PMID: 28681210     DOI: 10.1007/s11864-017-0490-0

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  80 in total

1.  A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.

Authors:  E Mangold; C Pagenstecher; M Leister; M Mathiak; A Rütten; W Friedl; P Propping; T Ruzicka; R Kruse
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  MSH6 mutation in Muir-Torre syndrome: could this be a rare finding?

Authors:  E Mangold; N Rahner; N Friedrichs; R Buettner; C Pagenstecher; S Aretz; W Friedl; T Ruzicka; P Propping; A Rütten; R Kruse
Journal:  Br J Dermatol       Date:  2007-01       Impact factor: 9.302

3.  American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing.

Authors: 
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

4.  Proposal of a Provisional Classification of Sebaceous Carcinoma Based on Hormone Receptor Expression and HER2 Status.

Authors:  Hee Young Na; Ji-Young Choe; Seon Ah Shin; Ho-Kyung Choung; Sohee Oh; Jin-Haeng Chung; Mira Park; Ji Eun Kim
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

5.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

6.  Histopathological review of sebaceous carcinoma of the eyelid.

Authors:  Patricia Rusa Pereira; Alexandre Nakao Odashiro; Abelardo A Rodrigues-Reyes; Zelia Maria S Correa; João Pessoa de Souza Filho; Miguel N Burnier
Journal:  J Cutan Pathol       Date:  2005-08       Impact factor: 1.587

7.  Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis.

Authors:  M C Southey; M A Young; J Whitty; S Mifsud; M Keilar; L Mead; L Trute; K Aittomäki; S A McLachlan; H Debinski; D J Venter; J E Armes
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

8.  Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis.

Authors:  J T Wolfe; R P Yeatts; M R Wick; R J Campbell; R R Waller
Journal:  Am J Surg Pathol       Date:  1984-08       Impact factor: 6.394

9.  Conjunctival map biopsy to determine pagetoid spread.

Authors:  A M Putterman
Journal:  Am J Ophthalmol       Date:  1986-07-15       Impact factor: 5.258

10.  Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality.

Authors:  Simone Ribero; Eugenio Sportoletti Baduel; Matteo Brizio; Franco Picciotto; Emi Dika; Maria Teresa Fierro; Giuseppe Macripò; Pietro Quaglino
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

View more
  15 in total

Review 1.  Current Treatment Options for Cutaneous Adnexal Malignancies.

Authors:  Hiroyuki Goto
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

Review 2.  Updates on the clinical diagnosis and management of ocular sebaceous carcinoma: a brief review of the literature.

Authors:  Yangfan Xu; Fang Li; Renbing Jia; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2018-06-27       Impact factor: 4.147

3.  Detection of Epstein-Barr Virus in 130 Cases of Eyelid Sebaceous Gland Carcinoma Using In Situ Hybridization.

Authors:  Huanhuan Gao; Lijuan Tang; Jianxian Lin; Wenxin Zhang; Yongping Li; Ping Zhang
Journal:  J Ophthalmol       Date:  2020-03-30       Impact factor: 1.909

4.  18F-FDG PET/CT for Response Assessment in Pediatric Sebaceous Carcinoma of the Parotid Gland.

Authors:  Adrien Holzgreve; Thomas Pfluger; Irene Schmid; Orlando Guntinas-Lichius; Wolfgang G Kunz; Jens Ricke; Peter Bartenstein; Nathalie L Albert; Marcus Unterrainer
Journal:  Diagnostics (Basel)       Date:  2020-11-06

5.  A recurrent case of extraocular sebaceous carcinoma with distant organ metastasis.

Authors:  Byeong Soo Kwon; Eui Han Chung; Jin Woo Kim
Journal:  Arch Craniofac Surg       Date:  2021-02-20

6.  Sebaceous carcinoma of the breast predominantly characterized by intraductal growth: a case report.

Authors:  Koichi Ohno; Toshihiro Okada; Toshitsugu Nakamura; Hiroshi Koyama
Journal:  Surg Case Rep       Date:  2020-02-24

7.  Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.

Authors:  Masahiro Tomonari; Mariko Shimada; Yasuyuki Nakada; Izumi Yamamoto; Munenari Itoh; Yusuke Koike; Akimitsu Kobayashi; Jun Miki; Hiroki Yamada; Takahiro Kimura; Shinya Saito; Kokichi Sugano; Shigeki Sekine; Hiroyasu Yamamoto; Akihiko Asahina; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2019-10-29       Impact factor: 2.388

8.  Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Authors:  Tiina Leivo; Johanna Sarmela; Maria Enckell-Aaltonen; Eva Dafgård Kopp; Caroline Schmitt; Peter B Toft; Haraldur Sigurdsson; Marita Uusitalo
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

9.  A rare concurrence of Muir-Torre-associated sebaceous carcinoma in the setting of a lipedematous scalp.

Authors:  Allison Shanks; Jake Laun; Amanda Holstein; Saksham Varshney; Jane Messina; Carl Wayne Cruse
Journal:  Case Reports Plast Surg Hand Surg       Date:  2020-10-19

10.  Aggressive sebaceous carcinoma of the scalp: a case report and literature review.

Authors:  Guihong Li; Jing Shen; Haiyan Huang; Ruili Chen; Guangtong Zhou
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.